drugset / Trial / NCT00709579

Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids

NCT00709579 ↗

RandomizedParallel-groupDouble-blind

Summary

Methodology :Phase III study, single centre, double blind, versus excipient, randomised, controlateral design. Selection of the patients :Number of subjects required 60 : * 30 patients needing an oral corticotherapy * 30 patients needing a topical corticotherapy

Timeline

Start
2008-06
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator RV3391A Unknown — Topical

Indications